Chemokine receptor 9 high-expression involved in the migration and invasion of the non-small-cell lung cancer cells

1. American Cancer Society. Cancer facts and figures. Atlanta (GA): American Cancer Society. 2007.Search in Google Scholar

2. Maziak DE, Markman BR, MacKay JA, Evans WK. Photodynamic therapy in non-small cell lung cancer: A systematic review. Ann Thorac Surg. 2004;77:1484-91.10.1016/j.athoracsur.2003.07.017Search in Google Scholar

3. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000; 355: 479-85.10.1016/S0140-6736(00)82038-3Search in Google Scholar

4. Campbell JJ, Butcher EC, Bowman EP. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing: developmental switches in chemokine response profiles during B cell differentiation and maturation. Curr Opin Immunol. 2000; 12:336-41.10.1016/S0952-7915(00)00096-0Open DOISearch in Google Scholar

5. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000; 12:121-7.10.1016/S1074-7613(00)80165-XOpen DOISearch in Google Scholar

6. Koenecke C, Forster R.CCR9 and inflammatory bowel disease. Expert Opin Ther Targets. 2009; 13:297-306.10.1517/1472822090276292819236152Search in Google Scholar

7. Richmond A. CCR9 homes metastatic melanoma cells to the small bowel. Clin Cancer Res. 2008; 14:621-3.10.1158/1078-0432.CCR-07-223518245518Open DOISearch in Google Scholar

8. Amersi FF, Terando AM, Goto Y, Scolyer RA, Thompson JF, Tran AN, et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin Cancer Res. 2008; 14:638-45.10.1158/1078-0432.CCR-07-2025276093118245522Open DOISearch in Google Scholar

9. Valdivia-Silva, Franco-Barraza J, Silva AL, Pont GD, Soldevila G, Meza I, et al. Garc_a-Zepeda EA. Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis.Cancer Lett. 2009; 283:176-85.10.1016/j.canlet.2009.03.04019409696Search in Google Scholar

10. Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW Jr. Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res. 2004; 10:8743-50.10.1158/1078-0432.CCR-04-026615623660Open DOISearch in Google Scholar

11. van den Oord J. The CCR9-CCL25 axis mediates melanoma metastasis to the small intestine. Nature Clinl Pract Oncol. 2008; 5:440-1.10.1038/ncponc117418577981Open DOISearch in Google Scholar

12. Johnson EL, Singh S, Johnson-Holidy C, Singh UP, Lillard JW. Role of CCL25-CCR9 interaction in ovarian cancer cell metastasis and survival. J Immunol. 2006; 176:S271.Search in Google Scholar

13. Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. nvolvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res. 2009; 19:2962-70.10.1158/1078-0432.CCR-08-249519383822Open DOISearch in Google Scholar

14. Xiaoling Tong, Lijun Zhang, Li Zhang, Hu M, Leng J, Yu B, et al. The mechanism of chemokine receptor 9 internalization triggered by interleukin 2 and interleukin4. Cell Molecul Immunol. 2009; 6:181-9.10.1038/cmi.2009.25400306119567201Search in Google Scholar

15. Schneider BJ. Non-small cell lung cancer staging: Proposed revisions to the TNM system. Cancer Imaging 2008; 8:181-18510.1102/1470-7330.2008.0029255650518824424Search in Google Scholar

16. Huang CC, Aronstam RS, Chen DR, Huang YW. Zinc oxide nanoparticles induce oxidative stress and alter calcium homeostasis in human bronchial epithelialcells (BEAS-2B). Free Rad Biol Med. 2008; 45:S31.Search in Google Scholar

17. Shafer SH, Williams CL. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment. Intern J Oncology. 2003; 23:389-400.Search in Google Scholar

18. MacDonald TJ, DeClerck YA, Laug WE. Urokinase induces receptor mediated brain tumor cell migration and invasion. J Neuro-Oncology. 1998; 40:215-26.10.1023/A:1006150506789Search in Google Scholar

19. Jinquan T, Frydenberg J, Mukaida N, Bonde J, Larsen CG, Matsushima K, et al. Recombinant human growth regulated oncogene-a induces T lymphocyte chemotaxis; a process regulated via interleukin-8 receptors by IFN-gamma, TNF-a, IL-4, IL-10 and IL-13. J Immunol. 1995; 155: 5359-68.Search in Google Scholar

20. Wang CL, Wang CI, Liao PC, Chen CD, Liang Y, Chuang WY, et al. Discovery of retinoblastomaassociated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome. J Proteome Res. 2009; 8:4428-40.10.1021/pr900160h19655816Open DOISearch in Google Scholar

21. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature (Lond). 2001; 411:375-9.10.1038/3507724111357145Search in Google Scholar

22. Kakinuma T, Hwang SM. Chemokines, chemokine receptors, and cancer metastasis. J Leukocyte Biol. 2006; 79:639-51.10.1189/jlb.110563316478915Open DOISearch in Google Scholar

23. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M. Chemokines in tumor progression and metastasis. Cancer Sci. 2005; 96:317-22.10.1111/j.1349-7006.2005.00059.x15958053Open DOISearch in Google Scholar

24. Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, et al. Role of beta 7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn’s disease. Gastroenterology. 2008; 134:2025-35.10.1053/j.gastro.2008.02.08518439426Search in Google Scholar

25. Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, et al. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol. 2010; 8:62-9.10.1186/1477-7819-8-62292759520649989Open DOISearch in Google Scholar

26. Sharma PK, Singh R, Novakovic KR, Eaton JW, Grizzle WE, Singh S. CCR9 mediates PI3K/AKTdependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide. Intern J Cancer. 2010; 9:2020-30.10.1002/ijc.2521920127861Open DOISearch in Google Scholar

27. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond). 2001; 410:50-6.10.1038/3506501611242036Search in Google Scholar

28. Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med. 2002; 195:1145-54.10.1084/jem.20011284219370911994419Search in Google Scholar

29. Zaballos A, Gutierrez J, Varona R, Ardavín C, Marquez G. Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. J Immunol. 1999;162:5671-5. Search in Google Scholar